Key result
Systemic p38δ deletion improves 10-day survival to ~80% in female mice after doxorubicin exposure.
Why the study?
Does p38δ genetic ablation prevent doxorubicin cardiotoxicity in mice?
Does p38δ genetic ablation prevent doxorubicin cardiotoxicity in mice?
Genetic ablation of p38δ provides sex-specific cardioprotection against doxorubicin-induced cardiotoxicity in female mice.
p38δ deletion may protect female mice from doxorubicin cardiotoxicity; leaves open whether selective inhibition merits human trials.
BACKGROUND The efficacy of an anthracycline antibiotic doxorubicin (DOX) as a chemotherapeutic agent is limited by dose-dependent cardiotoxicity. DOX is associated with activation of intracellular stress signaling pathways including p38 MAPKs. While previous studies have implicated p38 MAPK signaling in DOX-induced cardiac injury, the roles of the individual p38 isoforms, specifically, of the alternative isoforms p38γ and p38δ, remain uncharacterized. OBJECTIVES To determine the potential cardioprotective effects of p38γ and p38δ genetic deletion in mice subjected to acute DOX treatment. METHODS Male and female wild-type (WT), p38γ -/- , p38δ -/- and p38γ -/- δ -/- mice were injected with 30 mg/kg DOX and their survival was tracked for ten days. During this period cardiac function was assessed by echocardiography and electrocardiography and fibrosis by PicroSirius Red staining. Immunoblotting was performed to assess the expression of signaling proteins and markers linked to autophagy. RESULTS Significantly improved survival was observed in p38δ -/- female mice post-DOX relative to WT females, but not in p38γ -/- or p38γ -/- δ -/- male or female mice. The improved survival in DOX-treated p38δ -/- females was associated with decreased fibrosis, increased cardiac output and LV diameter relative to DOX-treated WT females, and similar to saline-treated controls. Structural and echocardiographic parameters were either unchanged or worsened in all other groups. Increased autophagy, as evidenced by increased LC3-II level, and decreased mTOR activation was also observed in DOX-treated p38δ -/- females. CONCLUSIONS p38δ plays a crucial role in promoting DOX-induced cardiotoxicity in female mice by inhibiting autophagy. Therefore, p38δ targeting could be a potential cardioprotective strategy in anthracycline chemotherapy. NEW AND NOTEWORTHY This study for the first time identifies the roles of the alternative p38γ and p38δ MAPK isoforms in promoting DOX-cardiotoxicity in a sex-specific manner. While p38γ systemic deletion did not affect DOX-cardiotoxicity, p38δ systemic deletion was cardioprotective in female but not in male mice. Cardiac structure and function were preserved in DOX-treated p38δ-/- females and autophagy was increased.
No takes yet. Share an insight, caveat, or question.
George et al. (2020) studied Anthracycline (doxorubicin)-induced cardiotoxicity. Systemic p38δ genetic deletion (p38δ-/-) with acute doxorubicin treatment vs. Wild-type (WT) mice treated with 30 mg/kg intraperitoneal doxorubicin was evaluated on 10-day survival rate in female mice post-doxorubicin (30 mg/kg) injection (p=<0.05). Systemic p38δ genetic deletion significantly improved 10-day survival in female mice treated with 30 mg/kg doxorubicin compared to wild-type females (80% vs. 0%, P < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: